New drug infusion targets tough cancers in early trial

NCT ID NCT07488676

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a new drug called ASP546C in people with advanced stomach, gastroesophageal junction, pancreatic, or certain other solid tumors. The drug is given as an infusion every 3 weeks. The study has two parts: Part 1 finds the best dose in stomach/GEJ cancer patients, and Part 2 tests that dose in pancreatic and other tumor types. The goal is to see if the drug can shrink tumors and to check for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duke Cancer Center Durham

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Indiana University (IU) Health - Multi-D Oncology Clinic

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • National Cancer Center Hospital

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa-shi, Chiba, Japan

  • Next Oncology - Austin

    RECRUITING

    Austin, Texas, 78758, United States

  • Next Oncology - Dallas

    RECRUITING

    Irving, Texas, 75039, United States

  • Next Oncology - Houston

    RECRUITING

    Houston, Texas, 77054, United States

  • START Los Angeles

    RECRUITING

    Los Angeles, California, 90025, United States

  • START Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • START Mountain Region

    RECRUITING

    West Valley City, Utah, 84119, United States

  • START New York

    RECRUITING

    Lake Success, New York, 10042, United States

  • START San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Koto-ku, Tokyo, Japan

  • UAB Medicine - UAB Hospital

    RECRUITING

    Birmingham, Alabama, 35249, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.